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IN VITRO 25HYDROXYLATION OF la,24-DIHYDROXYVITAMIN D3 IN VARIOUS 
RAT TISSUES 
I. htrod~on 
The 25-hydroxylation of vitamin Ds in the liver is 
the first step for vitamin Ds activation [l-3]. 
25-OH-Ds was shown formed from vitamin Ds in 
intact rats but not to a signii&ant level in the hepa- 
tectomized rats [ 1,2]. This suggests hat the transfor- 
mation ofvitamin Da to 25-OH-Da takes place mainly, 
if not only, irt the liver ~ The tr~sfor~tion of &amin 
Da to 255H-Ds was demonstrated using both per- 
fused rat liver and rat liver homogenate systems [31. 
However, vitamin D&Lhydroxylase activity was 
reported present in the kidney and intestine as well 
as in the liver of chick [4], indicating the distribution 
of the enzyme in various tissues. 
We have shown that lar,24(OHhDs is metabolized 
rapidly to lcw,24,25-(OH)sDa in rats [5,6] and the 
25” hydroxylation occurs mainly in the liver [S]. 
However, the possibility of 25hydroxylation in the 
tissues other than the liver has been suggested also, 
since a small amount of laJ4,25-(OH)sDs was formed 
from la;24fOffaDs in the hepatecto~d rats. 
This paper describes the 25-hydroxylation of 
la@&Xl)sDs and la-OH-Da using homogenates of 
rat liver, kidney, intestine, bone, adrenal and muscle. 
2. M&rials and metlmds 
2 .l . Compounds 
Tritium-labeled compounds, l~~~“r~q~.~H~D~ 
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(3.8 Ci/mol), la,24(R)~OH)s f24-3H]Ds (3.0 
Cifmmol) and la,24(~(OH)s [ 24-3H] Ds (3 .O 
Ci/mmol), were synthesized as in [5,7]. Non-radio- 
active la,25(0H)t~)2Ds, lar 24@)25(OH)sDs and 
la,24(,9)25{OH)sDs were synthesized as in [8] and 
[9 1, respectively. 
Wear&rig male Wistar ats were fed a vitamin 
D-deficient low calcium diet for 6 weeks f5]. 10% 
liver homogenates in 0.25 M sucrose were prepared 
with the aid of a Potter-Elvehjem homogenizer fitted 
with a teflon pestle. A portion (5 ml) of the homo- 
genates was then mixed with 10 ml phosphate buffer 
(pH 7.4) containing Mg- and NADPH-generating sys- 
tems as in [3]. The final concentrations were: 25 mM 
phosphate buffer (PH 7.4), 1.25 mM MgCls, 25 mM 
KCl, 5 mM ATP, 0.1 mM NADP, 40 mM nicotinam- 
ide, 5 mM sodium succinate, 5.6 mM glucose 6-phos- 
phate and 09 units glucose 6-phosphate dehydrogen- 
ase. The reaction was initiated by adding 1 .O @g 
~#~qR~~O~~ f3HlDa, 1~,2q~~O~ fsHlDa or 
ia-OH-j3H]Ds in 200 ~1 ethanol. The incubation was 
carried out with gentle shaking at 37°C for 2 h and 
30 ml methanol:chloroform (1: 1) was added to stop 
the reaction. 
2.3. Incubation of intestinal mucos~ homogenates 
Intestines from the vitamin D-deficient rats were 
rinsed with 0.9% NaQ solution, then the mucosa was 
scraped off from the serosa with a glass microscope 
slide. The intestinal mucosa (3 g) was homogenized 
with 30 ml 0.25 M sucrose in a Potter-Elvehj~ 
homoge~zer equipped with a Teflon pestle, The incu- 
bation was carried out with the same reactian mix- 
ture as for the liver homogenate incubations. The 
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Fig.1. The elution profiles from a Sephadex LH-20 column of the extracts of rat liver homogenates incubated either with 
1&!4(R)-(OH), [‘HID, (A), la,24(S)-(OH),[sH]D, (B) or ~wOH-[~H]D, (C)for 2 h by the method in [3]. Sephadex LH-20 
chromatographic profiles of lipid extracts from rat liver perfusates perfused with. 1.0 pg la,24(R)-(OH), [ 3H]D, (D), lu,24(S)- 
(OH), [‘HID, (E) or l~&H-[~fi]D, (F) for 2 h by the method in [ 151 as described [5]. Sephadex LH-20 column (1.5 X 25 cm) 
developed with chloroform:n-hexane:methanol(75:23:2) [ 161 for lo,24-(OH), [‘HID, and chloroform:n-hexane (65:35) [17] 
for lo-OH-( 3H]D,. 
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reaction was~t~ated by adding 50 ng ~~,~~~~~~- 
[3HJDs, l~~~~~U~~~3H~~~ or la-OH-~3HjDs 
in 200 ,ui ethanoi. The incubation was carried out 
with gentle shaking at 37°C for 2 h. 
2.4. Iizcubation of tissue homogenates other than 
intestirwl mucosa 
A portion (3 g) of the kidney, adrenal or muscle 
from vitamin R-deficient rats was homogenized with 
30 m.I 0.25 M sucrose in a Potter-Elvehjem homoge- 
nizer equipped with a Teflon pestle. The bones were 
collected and a 10% homogenate in 0.25 M sucrose 
was prepared using an Wra-Turrax, The ~n~uhat~on 
was BS with intestinal mucosa homogenates. 
2.5, Identification of Is24,2S-(OH)~‘HJD~ 
The polar metabolites of la,24(R)(OH)z [3H]D3 
and la,24(,5’)(OH)z [3H]Ds from a Sephadex LH-20 
column were co-chromatographed with synthetic 
lcu,24(R)25-(OH)sDs and lc~,24(,!925-(OH)sRs on 
a high-pressure liquid chromatography Hitachi model 
635, using a Du Pont Zorbax Sit cohnnn (2.1 X 250 
mm) and 3.5% methanol in dichloromethane as the 
eluting solvent) as in f IO]. 
The homogenates of various tissues from the rat 
were incubated with lc~,24(R)@H)~D~, lc~,24@‘)- 
(OH)?DJ or la-OH-D:, since it had been shown th&. 
la,24(OH)zDs was metabolized to lc~,24,25-(OH)sDs 
in vivo [5,6]. The chromatographic profiles on 
Sephadex LB-20 of the extracts of the liver homog- 
enates pre-incubated with the compounds are shown 
in fig.1, The tr~sformations of lar,24@)-(OH)~Ds 
and 1~,2q~~O~~~Ds to the ~orres~n~ng 25.hy- 
droxylated compounds were demon~rat~ by 
Sephadex LH-20 column ~o~to~aphy (fig.fA,B) 
and co-c~omato~aphy with the synthetic orn- 
pounds in a high-pressure liquid chromatograph. The 
transformation rates of lar,24(R)(OH)2D3 and 
1~,24(S)(OH)~Ds were 2.5% and 2.7%, respectively, 
and were almost he same as that of lar-OH-D3 to 
la,25(OH)1Ds, Homogenates that were heated to 
100°C for 10 min and incubated with either 1 a-OH-Ds 
or 1~~,24-(oH)~Ds were incapable of converting 
k-OH-Ds to ftr,25-(OH)& or lar,24-(Ol-&Ds to 
la,24,25@H)3Ds, 
The perfusion of rat liver with the perfusate con- 
Fig.2. Sephadex LH-20 ehroMa~o~ap~c profiles of tipid extracts from rat kidney bomogenat#3 or rat intestinal mucosa bomoge- 
Dates incubated with 50 ng la,24(R)-(OH), [sH]D3 (A,C) 01 k~,24@)-(OH)~ [‘HID3 (B&J) for 2 h respectively. Sephadex LH-20 
column chromatography wasas in fig.1. 
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taining la,Z4fR)-(OH)2D3t lo,24(S)-(OH)2Ds or 
lo-OH-D3 was carried out and the extracts of the 
perfusate were adyzed by ~~~~t~~raph~ on 
Sephadex L&20. As shown itl Q. f D-F, 13% af 
~~,Z~~~~U~~~~, 22% of ~~,2~~OH~~~ and 
14.7% of lo-OH-Da were metabolized to the 25hy- 
droxylated compounds. 
Fig.2 shows the results of the incubation of rat 
kidney homogenates with lar,24@)4OH)sDs or 
la,24(,!+(OH)1Ds. Both compounds were metabolized 
ta la,24(R)25@H)sRa (2.3%) and ltu;~24(&‘)25- 
(OH)sDs (2.1%) (fig.2A,B); the fractions of both 
metabohtes gave a single peak by Sephadex LH-20 
rechromatogra~hy and hid-~re~ure Iiquid chromato- 
graphy. 
The incubation of 1~,2~R~OH)~Ds or lo,24@)- 
(OH)sDs with the intestinal mucosa homogenates 
also gave the corresponding 25hydroxylated metab- 
olites; the transformation rates were I .9% and 1.70/o, 
respectively (fig.2C.D). On the other baud, incuba- 
tion of lcu,24(R)(OH)~Ds or la,24(5’)(OH)zDs with 
homogenates of bone, adrenal or muscle did not 
result in the formation of any metabohtes (not 
shown). 
As in the case of 1~,24~U~~D~~ la,25_fOH)sDs 
was produced by the incubation of la-OH-Da with 
homogenates of the liver, kidney and Intestine but 
none of the metabolite was formed by the incubation 
of bone, adrenal or muscle homogenates, 
4. Discussions 
The 25hydroxylation of vitamin Ds takes place in 
the liver [l-3]. 25Hydroxylation of vitamin De and 
la(-OH-D3 was studied using homogenates of liver and 
intestine of the rat and hydroxylation reported to 
occur in the liver but not in the intestine fll]. How- 
ever, we have explored the presaxe of 25hydroxylase 
in various tissues of rats since, when lo-OH-D3 or 
lcu,24-(0H)zDs was adm~istered to hepatectomized 
rats, the corresponding 25-hydroxy derivative was 
detected, suggesting the presence of 25hydroxylase 
in other tissues as well as in the liver (S. I. et al in 
preparation). The result indicated that 25hydroxylase 
exists in liver, kidney and intestine of rats but not in 
bone, adrenal and muscle. The corresponding 25 
hydroxy derivative of lo-OH-Ds or la~4(OH)sD3 
gradu~ly increased uring the incubation period of 
2 h and attained a maximal Ievel. The 25-hydroxyIa- 
tion of lo-OH-D3 or 1~~2~~H~~~ did not occur 
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when the steroid was incubated with boiled homog- 
enates of various tissues. The above implies that 
25-hydroxylation isnot oxidation by air but an 
enzymic reaction. 
It is well known that there are two types of 25 
hydroxylation in rat liver f 1 Z- 141.25”Hydroxylation 
of vitamiu Da was’compared with that of dihydro- 
tachysterols (DHTs) [ 121 and it was concluded that 
the latter was different from the former which was 
regulated by metabolic ontrol. It was reported 
[13,14] that 25hydroxylation of lo-OH-Da was the 
same type with DHTs and we have found [S] that of 
lrr~4-(0H)zDs in Iiver to be DHTs kind- Our next 
problem is whether the 25-hy~oxyla~on of lar,24- 
(UH)sDs in kidney and intestine is under metabolic 
control. 
References 
[1] Pon&mr G. and DeLuca, H. F. (1969) J. Clin. Invest. 
48,1273-1279. 
[2 ] Ponchm, G., Kennan, A. L. and DeLuca, H. F. (1969) 
J. Clin. Invest. 48,2032-2037. 
131 HOI.&@;, M. and DeLuca, H. F. (1969) Biochem. 
Biophys. Res. Commun. 36,251-256. 
[4] Tucker, G. XII, Gagnon, R. E. and Haussler, hf. R, 
(1973) Arch. 3iocbem. Blophys. 155,47-57. 
[ 5] Ishizuka, S., Bam&, K., Naruchi, T., Hash&n&o, t., 
Noguchi, T_ and Hosoya, N. (1980) J. Biochem. 88, 
87-95, 
[6] ishizuka, S., Bannai, K., Naruchi, T. and Hasbimoto, Y, 
(1979) Biochem. Biophys. Res. Commua. 90,904-910, 
[7] Bann& K., Ishizuka, S., Naruchi, T. and Washimoto, Y. 
(1979) J. Ster. Biochem. 10,411-418. 
[8] Rubiu-Liphtbourn, J., Morisaki, M. and Ikekawa, N. 
(1973) Cbem. Pbarm. Bull. 21,1854-1856. 
191 Ikekawa, N., Morisaki, M., Koizumi, N., Kata, Y. and 
Takeshita, T. (1975) Chem. Pharm. Bull. 23,695-697. 
fkekawa, N,, and Koizuml, N. (1976) J. Chromatogr_ 
119,227-232. 
Holick, S. A., Holick, M. F_, Tavela, T. E., Scfuroes, 
8. K. and DeLuea, H. F. (1976) J_ Biol. Chem. 251, 
1025-1028. 
Bhattacharyya, M. H. and DeLuca, H. F. (1973) J. 
Biol. Chem. 248,2973-2979. 
Fukushima, M., Suzuki, Y., Tohira, Y., Nishii, Y., 
Suzuki, M., Sasaki, S., and Suda, T. (1976) FEBS Lett. 
65,21J-214. 
Fukusbima, M., Nishii, Y., Suzuki M. and Suds, T. 
(1978) Biochem. J. 170,495-502. 
Mortimoxe, G. E. (1961) Am. J. Physiol. 200, 
1315-1319. 
Fro&k, C. A. and DeLuca, H. F. (1971) Arch, Bio- 
them, Biophys. 147,143-147. 
Holick, M. F. and DeLuca, H. F. (1971) 3. Lipid Res. 
12,406-465. 
